FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Jan Gerstoft

Research Profile

Disorders

Living Beings

HIV-1

Procedures

Geographic Areas

Denmark

Chemicals & Drugs

Concepts & Ideas

Phenomena

HIV Seropositivity

Activities & Behaviors

Homosexuality

Anatomy

CD4-Positive T-Lymphocytes

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Rebecca Legarth; Lars Nørregård Nielsen; Court Pedersen; Gitte Pedersen; Jan Gerstoft; Marie Helleberg; Janne Jensen; Gitte Kronborg; Carsten Schade Larsen; Niels Obel
Anal carcinoma in HIV-infected patients in the period 1995-2009: A Danish nationwide cohort study.
Mohammad Salem; Henrik Ullum; Andreas Ronit; Julie C Gaardbo; Jan Gerstoft; Tamara T Lund; Susanne D Nielsen
Altered balance between IL-17A- and IL-17F-producing Th17 cells in HIV-infected patients.
Andreas Ronit; Mohammad Salem; Henrik Ullum; Julie C Gaardbo; Jan Gerstoft; Hans J Hartling; Susanne D Nielsen
Dysregulation of toll-like receptor (TLR) 2 expression on monocytes and upregulation of the frequency of T cells expressing TLR2 in patients with chronic hepatitis C virus infection.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Jan Gerstoft (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2013: Rebecca Legarth; Lars Nørregård Nielsen; Court Pedersen; Gitte Pedersen; Jan Gerstoft; Marie Helleberg; Janne Jensen; Gitte Kronborg; Carsten Schade Larsen; Niels Obel
Anal carcinoma in HIV-infected patients in the period 1995-2009: A Danish nationwide cohort study.
Scandinavian journal of infectious diseases 2013;45(6):453-9.
2013: Mohammad Salem; Henrik Ullum; Andreas Ronit; Julie C Gaardbo; Jan Gerstoft; Tamara T Lund; Susanne D Nielsen
Altered balance between IL-17A- and IL-17F-producing Th17 cells in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2013;63(1):e28-30.
2013: Andreas Ronit; Mohammad Salem; Henrik Ullum; Julie C Gaardbo; Jan Gerstoft; Hans J Hartling; Susanne D Nielsen
Dysregulation of toll-like receptor (TLR) 2 expression on monocytes and upregulation of the frequency of T cells expressing TLR2 in patients with chronic hepatitis C virus infection.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2013;121(5):437-46.
2013: Marie Helleberg; Gitte Kronborg; Carsten Schade Larsen; Niels Obel; Court Pedersen; Gitte Pedersen; Jan Gerstoft
Poor CD4 response despite viral suppression is associated with increased non-AIDS-related mortality among HIV patients and their parents.
AIDS (London, England) 2013;27(6):1021-6.
2013: Margit Hørup Larsen; Lise Wegner Thørner; Rutendo Zinyama; Trine Baldorf Berg; Christian Erikstrup; Jan Gerstoft; Exnevia Gomo; Per Kallestrup; Henrik Ullum
HLA-G 3' untranslated region 14-base pair deletion: association with poor survival in an HIV-1-infected Zimbabwean population.
The Journal of infectious diseases 2013;207(6):903-6.
2013: Marie Helleberg; Gitte Kronborg; Carsten Schade Larsen; Børge G Nordestgaard; Shoaib Afzal; Jan Gerstoft; Court Pedersen; Gitte Pedersen; Niels Obel
Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(5):727-34.
2013: Ingrid Karlsson; Ingrid Kromann; Gitte Kronborg; Lasse Vinner; Peter Andersen; Lars Vibe Andreasen; Lea Brandt; Jan Gerstoft; Anders Fomsgaard
Adjuvanted HLA-supertype restricted subdominant peptides induce new T-cell immunity during untreated HIV-1-infection.
Clinical immunology (Orlando, Fla.) 2013;146(2):120-30.
2013: Birgitte Lindegaard; Christian Frosig; Jan Gerstoft; Thomas Grøndahl; Pernille Hojman; Thine Hvid; Bente Klarlund Pedersen
Expression of fibroblast growth factor-21 in muscle is associated with lipodystrophy, insulin resistance and lipid disturbances in patients with HIV.
PloS one 2013;8(3):e55632.
2013: Line D Rasmussen; Court Pedersen; Jan Gerstoft; Gitte Kronborg; Carsten Schade Larsen; Niels Obel
Statin therapy and mortality in HIV-infected individuals; a Danish nationwide population-based cohort study.
PloS one 2013;8(3):e52828.
2013: Anne Audelin; Susan A Cowan; Louise B Jørgensen; Claus Nielsen; Niels Obel; Jan Gerstoft
Phylogenetics of the Danish HIV epidemic: the role of very late presenters in sustaining the epidemic.
Journal of acquired immune deficiency syndromes (1999) 2013;62(1):102-8.
2013: Andreas Knudsen; Anders B Mathiasen; René H Worck; Jan Gerstoft; Jens Kastrup; Terese L Katzenstein; Andreas Kjaer; Anne-Mette Lebech
Angiographic features and cardiovascular risk factors in human immunodeficiency virus-infected patients with first-time acute coronary syndrome.
The American journal of cardiology 2013;111(1):63-7.
2012: Frederikke F Rönsholt; Henrik Ullum; Jan Gerstoft; Terese L Katzenstein; Sisse R Ostrowski
T-cell subset distribution in HIV-1-infected patients after 12 years of treatment-induced viremic suppression.
Journal of acquired immune deficiency syndromes (1999) 2012;61(3):270-8.
2012: Magnus G Rasch; Court Pedersen; Frederik N Engsig; Bo Feldt-Rasmussen; Jan Gerstoft; Ole Kirk; Gitte Kronborg; Niels Obel
Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.
Scandinavian journal of infectious diseases 2012;44(9):689-96.
2012: H J Hartling; L S Knudsen; M R Clausen; J C Gaardbo; Jan Gerstoft; A Ronit; Kristin Skogstrand; Henrik Ullum; B Vainer; Susanne D Nielsen
CD4⁺ and CD8⁺ regulatory T cells (Tregs) are elevated and display an active phenotype in patients with chronic HCV mono-infection and HIV/HCV co-infection.
Scandinavian journal of immunology 2012;76(3):294-305.
2012: Susan Alice Cowan; Jan Gerstoft; Jakob Haff; Jens Nielsen; Annette Hartvig Christiansen; Niels Obel
Stable incidence of HIV diagnoses among Danish MSM despite increased engagement in unsafe sex.
Journal of acquired immune deficiency syndromes (1999) 2012;61(1):106-11.
2012: Inge Nordgaard-Lassen; Pernille Ravn; Inge Juul Sørensen; Klaus Theede; Lone Tjellesen; Erika Belard; Jens Frederik Dahlerup; Jan Gerstoft; Jens Kjeldsen; Knud Kragballe
Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatment.
Danish medical journal 2012;59(7):C4480.
2012: Ulrik Sloth Kristoffersen; Anne-Mette Lebech; Jann Mortensen; Jan Gerstoft; Henrik Gutte; Andreas Kjaer
Changes in lung function of HIV-infected patients: a 4.5-year follow-up study.
Clinical physiology and functional imaging 2012;32(4):288-95.
2012: Margit Hørup Larsen; Lise Wegner Thørner; Rutendo Zinyama; Janne Amstrup; Christian Erikstrup; Jan Gerstoft; Exnevia Gomo; Per Kallestrup; Henrik Ullum
CCL3L gene copy number and survival in an HIV-1 infected Zimbabwean population.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2012;12(5):1087-93.
2012: Marie Helleberg; Janne Jensen; Gitte Kronborg; Olav Larsen; Alex Lund Laursen; Lars Nielsen; Frederik N Engsig; Jan Gerstoft; Gitte Pedersen; Niels Obel
Late presenters, repeated testing, and missed opportunities in a Danish nationwide HIV cohort.
Scandinavian journal of infectious diseases 2012;44(4):282-8.
2012: Marie Helleberg; Gitte Kronborg; Carsten Schade Larsen; Frederik N Engsig; Jan Gerstoft; Court Pedersen; Gitte Pedersen; Niels Obel
Retention in a public healthcare system with free access to treatment: a Danish nationwide HIV cohort study.
AIDS (London, England) 2012;26(6):741-8.
2012: Jan Gerstoft; Anders Fomsgaard
[New times for the treatment of chronic hepatitis C].
Ugeskrift for laeger 2012;174(12):795.
2012: Inger Hee Mabuza Mathiesen; Susan Cowan; Jan Gerstoft; Jenny Dahl Knudsen; Thomas Benfield
Outcome of HIV-1-associated cryptococcal meningitis, Denmark 1988-2008.
Scandinavian journal of infectious diseases 2012;44(3):197-200.
2012: Line D Rasmussen; Court Pedersen; Jan Gerstoft; Gitte Kronborg; Elisabeth R Mathiesen; Niels Obel
Risk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort study.
PloS one 2012;7(9):e44575.
2012: Frederikke Falkencrone Rönsholt; Henrik Ullum; Terese Lea Katzenstein; Sisse Rye Ostrowski; Jan Gerstoft
T cell subsets in HIV infected patients after successful combination antiretroviral therapy: impact on survival after 12 years.
PloS one 2012;7(7):e39356.
2012: Julie C Gaardbo; Jan Gerstoft; Hans J Hartling; Susanne D Nielsen
Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors.
AIDS research and treatment 2012;2012():161584.
2012: Julie C Gaardbo; Jan Gerstoft; Hans J Hartling; Susanne D Nielsen
Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions.
Clinical & developmental immunology 2012;2012():670957.
2012: Andrew E Armitage; Chih-Hao Chang; Koen Deforche; Lars Fugger; Jan Gerstoft; Beatrice Kramer; Andrew McMichael; Andrew Rambaut; Edmund Wee; John J Welch; Astrid K N Iversen
APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon.
PLoS genetics 2012;8(3):e1002550.
2012: Ole S Søgaard; Henrik T Sørensen; Lars Ostergaard; Birgit Røge; Jan Gerstoft; Gitte Kronborg; Nicolai Lohse; Niels Obel
Morbidity and risk of subsequent diagnosis of HIV: a population based case control study identifying indicator diseases for HIV infection.
PloS one 2012;7(3):e32538.
2011: Line D Rasmussen; Court Pedersen; Jan Gerstoft; Line Kessel; Gitte Kronborg; Laleh D Molander; Niels Obel
Risk of cataract surgery in HIV-infected individuals: a Danish Nationwide Population-based cohort study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;53(11):1156-63.
2011: Anne Audelin; Jan Gerstoft; Janne Jensen; Alex Laursen; Lars Mathiesen; Claus Nielsen; Henrik Nielsen; Lars Nielsen; Niels Obel; Court Pedersen; Louise B Jørgensen
Molecular phylogenetics of transmitted drug resistance in newly diagnosed HIV Type 1 individuals in Denmark: a nation-wide study.
AIDS research and human retroviruses 2011;27(12):1283-90.
2011: Line D Rasmussen; Court Pedersen; Hanne Christensen; Frederik N Engsig; Jan Gerstoft; Gitte Kronborg; Niels Obel
Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study.
AIDS (London, England) 2011;25(13):1637-46.
2011: Nicolai Lohse; Lars Nielsen; Jan Gerstoft; Gitte Kronborg; Carsten Schade Larsen; Court Pedersen; Gitte Pedersen; Henrik Toft Sørensen; Niels Obel
Comorbidity acquired before HIV diagnosis and mortality in persons infected and uninfected with HIV: a Danish population-based cohort study.
Journal of acquired immune deficiency syndromes (1999) 2011;57(4):334-9.
2011: Kirsten Salado-Rasmussen; Zahra Persson Theilgaard; Mercy Chiduo; Jan Gerstoft; Court Pedersen; Terese L Katzenstein
Good performance of an immunoassay based method for nevirapine measurements in human breast milk.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2011;49(7):1171-5.
2011: Sverre Høie; Lene Surland Knudsen; Jan Gerstoft
Lymphogranuloma venereum proctitis: a differential diagnose to inflammatory bowel disease.
Scandinavian journal of gastroenterology 2011;46(4):503-10.
2011: L D Rasmussen; M Dybdal; Jan Gerstoft; Gitte Kronborg; Carsten Schade Larsen; Court Pedersen; G Pedersen; J Jensen; L Pedersen; Henrik Toft Sørensen; Niels Obel
HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study.
HIV medicine 2011;12(4):202-10.
2011: Marie Rathcke Lillemark; Jan Gerstoft; Niels Obel; Gitte Kronborg; Court Pedersen; Louise B Jørgensen; Tina Vasehus Madsen; Terese Lea Katzenstein
Characterization of HIV-1 from patients with virological failure to a boosted protease inhibitor regimen.
Journal of medical virology 2011;83(3):377-83.
2011: Tavs Qvist; Frederik Engsig; Gitte Kronborg; Carsten Schade Larsen; Birgit T Røge; Jan Gerstoft; Niels Obel
Predictors of unsafe sex among HIV patients in Denmark: a population-based cohort study.
Scandinavian journal of infectious diseases 2011;43(3):181-7.
2011: A B Hansen; Niels Obel; Henrik Nielsen; Court Pedersen; Jan Gerstoft
Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial.
HIV medicine 2011;12(3):157-65.
2011: François-Xavier Lescure; Lars Haukali Omland; Frederik Neess Engsig; Casper Roed; Jan Gerstoft; Gilles Pialoux; Gitte Kronborg; Carsten Schade Larsen; Niels Obel
Incidence and impact on mortality of severe neurocognitive disorders in persons with and without HIV infection: a Danish nationwide cohort study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(2):235-43.
2011: Klaus F Kofoed; Finn Rønholt; Jan Gerstoft; Carsten Sand
[Herpes zoster: clinical manifestation, diagnosis and treatment].
Ugeskrift for laeger 2011;173(2):114-9.
2011: Klaus F Kofoed; Finn Rønholt; Jan Gerstoft; Carsten Sand
[Prevention of herpes zoster by vaccination].
Ugeskrift for laeger 2011;173(2):110-4.
2011: Frederik N Engsig; Jan Gerstoft; Gitte Kronborg; Carsten Schade Larsen; Court Pedersen; Gitte Pedersen; Niels Obel
Head and neck cancer in HIV patients and their parents: a Danish cohort study.
Clinical epidemiology 2011;3():217-27.
2011: Zahra P Theilgaard; Ib C Bygbjerg; Mercy G Chiduo; Jan Gerstoft; Terese L Katzenstein; Martha M Lemnge; Christiane Pahl; Britt P Tersbøl
Addressing the fear and consequences of stigmatization - a necessary step towards making HAART accessible to women in Tanzania: a qualitative study.
AIDS research and therapy 2011;8():28.
2011: Niels Obel; Lars Haukali Omland; Court Pedersen; Gitte Pedersen; Henrik Toft Sørensen; Gitte Kronborg; Carsten Schade Larsen; Jan Gerstoft
Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort study.
PloS one 2011;6(7):e22698.
2010: Helene Mens; Mary Kearney; Ann Wiegand; Wei Shao; Kristian Schønning; Jan Gerstoft; Niels Obel; Frank Maldarelli; John W Mellors; Thomas Benfield; John M Coffin
HIV-1 continues to replicate and evolve in patients with natural control of HIV infection.
Journal of virology 2010;84(24):12971-81.
2010: Mette Vang Larsen; Lars Haukali Omland; Jan Gerstoft; Birgit T Røge; Carsten Schade Larsen; Gitte Pedersen; Niels Obel; Gitte Kronborg
Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
Scandinavian journal of infectious diseases 2010;42(11-12):917-23.
2010: Hans-Jürgen Stellbrink; Chloe Orkin; Jose Ramon Arribas; Juliet Compston; Jan Gerstoft; Eric Van Wijngaerden; Adriano Lazzarin; Giuliano Rizzardini; Herman G Sprenger; John Lambert; Gunta Sture; David Leather; Sara Hughes; Patrizia Zucchi; Helen Pearce
Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;51(8):963-72.
2010: Ulrik Sloth Kristoffersen; Niels Wiinberg; Claus Leth Petersen; Jan Gerstoft; Henrik Gutte; Anne-Mette Lebech; Andreas Kjaer
Reduction in coronary and peripheral vasomotor function in patients with HIV after initiation of antiretroviral therapy: a longitudinal study with positron emission tomography and flow-mediated dilation.
Nuclear medicine communications 2010;31(10):874-80.
2010: Ellen Sloth Andersen; Jan Gerstoft; Nina Weis
Reactivation of hepatitis D virus after chemotherapy for diffuse large B cell lymphoma despite lamivudine prophylaxis.
International journal of hematology 2010;92(2):378-80.
2010: F N Engsig; L H Omland; M V Larsen; L D Rasmussen; T Qvist; Jan Gerstoft; Niels Obel
Risk of high-level viraemia in HIV-infected patients on successful antiretroviral treatment for more than 6 months.
HIV medicine 2010;11(7):457-61.
2010: Amit C Achhra; Janaki Amin; Matthew G Law; Sean Emery; Jan Gerstoft; Fred M Gordin; Michael J Vjecha; James D Neaton; David A Cooper
Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients.
AIDS (London, England) 2010;24(12):1877-86.
2010: Mette V Larsen; Lars H Omland; Jan Gerstoft; Carsten Schade Larsen; Janne Jensen; Niels Obel; Gitte Kronborg
Impact of injecting drug use on mortality in Danish HIV-infected patients: a nation-wide population-based cohort study.
Addiction (Abingdon, England) 2010;105(3):529-35.
2010: Christian Erikstrup; Gitte Kronborg; Nicolai Lohse; Sisse R Ostrowski; Jan Gerstoft; Henrik Ullum
T-cell dysfunction in HIV-1-infected patients with impaired recovery of CD4 cells despite suppression of viral replication.
Journal of acquired immune deficiency syndromes (1999) 2010;53(3):303-10.
2010: Niels Obel; D K Farkas; Gitte Kronborg; Carsten Schade Larsen; G Pedersen; A Riis; Court Pedersen; Jan Gerstoft; Henrik T Sørensen
Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study.
HIV medicine 2010;11(2):130-6.
2010: Frederik Neess Engsig; Ann-Brit Eg Hansen; Jan Gerstoft; Gitte Kronborg; Carsten Schade Larsen; Niels Obel
Inpatient admissions and outpatient visits in persons with and without HIV infection in Denmark, 1995-2007.
AIDS (London, England) 2010;24(3):457-61.
2010: Jose R Arribas; Andrzej Horban; Jan Gerstoft; Gerdt Fätkenheuer; Mark Nelson; Nathan Clumeck; Federico Pulido; Andrew Hill; Yvon van Delft; Thomas Stark; Christiane Moecklinghoff
The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml.
AIDS (London, England) 2010;24(2):223-30.
2010: Frederik N Engsig; Jan Gerstoft; Gitte Kronborg; Carsten Schade Larsen; Gitte Pedersen; Birgit T Røge; Janne Jensen; Lars N Nielsen; Niels Obel
Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study.
BMC infectious diseases 2010;10():318.
2010: Frederik N Engsig; Jan Gerstoft; Gitte Kronborg; Carsten Schade Larsen; Gitte Pedersen; Anne M Audelin; Louise B Jørgensen; Niels Obel
Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen.
Clinical epidemiology 2010;2():145-51.
2010: Line D Rasmussen; Lars H Omland; Court Pedersen; Jan Gerstoft; Gitte Kronborg; Janne Jensen; Niels Obel
Risk of myocardial infarction in parents of HIV-infected Individuals: a population-based Cohort Study.
BMC infectious diseases 2010;10():169.
2010: Yazdan Yazdanpanah; Joep Lange; Jan Gerstoft; Gus Cairns
Earlier testing for HIV--how do we prevent late presentation?
Antiviral therapy 2010;15 Suppl 1():17-24.
2010: Ase B Andersen; Ian Law; Karen S Krabbe; Helle Bruunsgaard; Sisse R Ostrowski; Henrik Ullum; Liselotte Højgaard; Annemette Lebech; Jan Gerstoft; Andreas Kjaer
Cerebral FDG-PET scanning abnormalities in optimally treated HIV patients.
Journal of neuroinflammation 2010;7():13.
2009: Judith M Haissman; Lasse S Vestergaard; Samuel Sembuche; Christian Erikstrup; Bruno P Mmbando; Samuel Mtullu; Martha M Lemnge; Jan Gerstoft; Henrik Ullum
Plasma cytokine levels in Tanzanian HIV-1-infected adults and the effect of antiretroviral treatment.
Journal of acquired immune deficiency syndromes (1999) 2009;52(4):493-7.
2009: Søren Banke; Marie R Lillemark; Jan Gerstoft; Niels Obel; Louise B Jørgensen
Positive selection pressure introduces secondary mutations at Gag cleavage sites in human immunodeficiency virus type 1 harboring major protease resistance mutations.
Journal of virology 2009;83(17):8916-24.
2009: Henrik Kloverpris; Ingrid Karlsson; Jesper Bonde; Mette Thorn; Lasse Vinner; Anders E Pedersen; Julie L Hentze; Betina S Andresen; Inge M Svane; Jan Gerstoft; Gitte Kronborg; Anders Fomsgaard
Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes.
AIDS (London, England) 2009;23(11):1329-40.
2009: Stefan Tenzer; Edmund Wee; Anne Burgevin; Guillaume Stewart-Jones; Lone Friis; Kasper Lamberth; Chih-hao Chang; Mikkel Harndahl; Mirjana Weimershaus; Jan Gerstoft; Nadja Akkad; Paul Klenerman; Lars Fugger; E Yvonne Jones; Andrew J McMichael; Søren Buus; Hansjörg Schild; Peter van Endert; Astrid K N Iversen
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance.
Nature immunology 2009;10(6):636-46.
2009: Jan Gerstoft; Lars Mathiesen; Jens D Lundgren; Henrik I Nielsen; Court Pedersen; Niels Obel; Alex Laursen
[Risk of virus transmission from well-treated patients with HIV?].
Ugeskrift for laeger 2009;171(13):1085.
2009: Ole Kirk; Jan Gerstoft; Jens D Lundgren; Niels Obel
[Major breakthroughs in the medical treatment].
Ugeskrift for laeger 2009;171(10):787-9.
2009: Jan Gerstoft; Peter Skinhøj
[Where is the HIV hiding--in the patient and in the population?].
Ugeskrift for laeger 2009;171(4):207.
2009: Anne Audelin; Nicolai Lohse; Niels Obel; Jan Gerstoft; Louise B Jørgensen
The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005.
Antiviral therapy 2009;14(7):995-1000.
2009: Ole S Søgaard; Nicolai Lohse; Jan Gerstoft; Gitte Kronborg; Lars Østergaard; Court Pedersen; Gitte Pedersen; Henrik Toft Sørensen; Niels Obel
Mortality after hospitalization for pneumonia among individuals with HIV, 1995-2008: a Danish cohort study.
PloS one 2009;4(9):e7022.
2009: Frederik Neess Engsig; Ann-Brit Eg Hansen; Lars Haukali Omland; Gitte Kronborg; Jan Gerstoft; Alex Lund Laursen; Court Pedersen; Christian Backer Mogensen; Lars Nielsen; Niels Obel
Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
The Journal of infectious diseases 2009;199(1):77-83.
2008: Sisse R Ostrowski; Terese L Katzenstein; Bente Klarlund Pedersen; Jan Gerstoft; Henrik Ullum
Residual viraemia in HIV-1-infected patients with plasma viral load
Scandinavian journal of immunology 2008;68(6):652-60.

2008: Ole S Sogaard; Nicolai Lohse; Jan Gerstoft; Gitte Kronborg; Lars Ostergaard; Court Pedersen; Gitte Pedersen; Henrik Toft Sørensen; Niels Obel
Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(10):1345-53.
2008: Anne-Mette Lebech; Ulrik Sloth Kristoffersen; Niels Wiinberg; Kristian Kofoed; Ove Andersen; Birger Hesse; Claus Leth Petersen; Jan Gerstoft; Andreas Kjaer
Coronary and peripheral endothelial function in HIV patients studied with positron emission tomography and flow-mediated dilation: relation to hypercholesterolemia.
European journal of nuclear medicine and molecular imaging 2008;35(11):2049-58.
2008: Birgitte Lindegaard; Torben Hansen; T Hvid; Gerrit van Hall; Peter Plomgaard; Susanne Ditlevsen; Jan Gerstoft; Bente Klarlund Pedersen
The effect of strength and endurance training on insulin sensitivity and fat distribution in human immunodeficiency virus-infected patients with lipodystrophy.
The Journal of clinical endocrinology and metabolism 2008;93(10):3860-9.
2008: Christian Erikstrup; Per Kallestrup; Rutendo B L Zinyama-Gutsire; Exnevia Gomo; Govert van Dam; André M Deelder; Anthony Butterworth; Bente Klarlund Pedersen; Sisse R Ostrowski; Jan Gerstoft; Henrik Ullum
Schistosomiasis and infection with human immunodeficiency virus 1 in rural Zimbabwe: systemic inflammation during co-infection and after treatment for schistosomiasis.
The American journal of tropical medicine and hygiene 2008;79(3):331-7.
2008: Terese L Katzenstein; Ann Berith Petersen; Louise B Jørgensen; Tine Johanne Strand; Tina Vasehus Madsen; Jan Gerstoft
Seventeen-year-old mother-to-child HIV type 1 transmission identified by phylogeny and signature patterns.
AIDS research and human retroviruses 2008;24(8):1117-20.
2008: Tina Vasehus Madsen; Nicolai Lohse; Ea Stilling Jensen; Niels Obel; Karin Ladefoged; Jan Gerstoft; Ann Berith Petersen; Claus Nielsen; Louise B Jørgensen
Short communication: high prevalence of drug-resistant human immunodeficiency virus type 1 in treatment-naïve patients in Greenland.
AIDS research and human retroviruses 2008;24(8):1073-7.
2008: Christian Erikstrup; Per Kallestrup; Rutendo B L Zinyama-Gutsire; Exnevia Gomo; Margrethe Lüneborg-Nielsen; Jan Gerstoft; Jörg Schüpbach; Henrik Ullum; Terese L Katzenstein
p24 as a predictor of mortality in a cohort of HIV-1-infected adults in rural Africa.
Journal of acquired immune deficiency syndromes (1999) 2008;48(3):345-9.
2008: Ulrik Sloth Kristoffersen; Anne-Mette Lebech; Jan Gerstoft; Birger Hesse; Claus Leth Petersen; Henrik Gutte; Andreas Kjaer
Right and left cardiac function in HIV-infected patients investigated using radionuclide ventriculography and brain natriuretic peptide: a 5-year follow-up study.
HIV medicine 2008;9(3):180-6.
2008: Simon Høegh; Nicolai Lohse; Ann-Brit Eg Hansen; Jan Gerstoft; Gitte Kronborg; Carsten Schade Larsen; Court Pedersen; Gitte Pedersen; Alex Lund Laursen; Birgit Kvinesdal; Axel Møller; Niels Obel
[Changes in immunological status among newly-diagnosed HIV-infected in Denmark 1995-2005].
Ugeskrift for laeger 2008;170(9):740-4.
2008: Ann-Brit Eg Hansen; Jan Gerstoft; Ole Kirk; Lars Mathiesen; Court Pedersen; Henrik Nielsen; Søren Jensen-Fangel; Henrik Toft Sørensen; Niels Obel
Unmeasured confounding caused slightly better response to HAART within than outside a randomized controlled trial.
Journal of clinical epidemiology 2008;61(1):87-94.
2008: Tina Vasehus Madsen; Jan Gerstoft; Claus Nielsen; Louise B Jørgensen
Reappearance of an 11-year-old sequence in an HIV-1 infected patient during treatment interruption.
Scandinavian journal of infectious diseases 2008;40(2):174-82.
2007: Christian Erikstrup; Per Kallestrup; Rutendo B Zinyama-Gutsire; Exnevia Gomo; Anthony Butterworth; Bente Klarlund Pedersen; Sisse R Ostrowski; Jan Gerstoft; Henrik Ullum
Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.
AIDS (London, England) 2007;21(17):2283-91.
2007: Betina S Andresen; Lasse Vinner; Sheila Tuyet Tang; Karoline Bragstad; Gitte Kronborg; Jan Gerstoft; Sylvie Corbet; Anders Fomsgaard
Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine.
AIDS research and human retroviruses 2007;23(11):1442-8.
2007: Anne-Mette Lebech; Ulrik Sloth Kristoffersen; Jesper Mehlsen; Niels Wiinberg; Claus Leth Petersen; Birger Hesse; Jan Gerstoft; Andreas Kjaer
Autonomic dysfunction in HIV patients on antiretroviral therapy: studies of heart rate variability.
Clinical physiology and functional imaging 2007;27(6):363-7.
2007: Ulrik S Justesen; Zoe Fox; Court Pedersen; Pedro Cahn; Jan Gerstoft; Nathan Clumeck; Marcelo H Losso; Barry Peters; Niels Obel; Antonella Castagna; Ulrik B Dragsted; Jens D Lundgren
Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trials.
Basic & clinical pharmacology & toxicology 2007;101(5):339-44.
2007: Zoe Fox; Anna Maria Geretti; Jesper Kjaer; Ulrik B Dragsted; Andrew N Phillips; Jan Gerstoft; Schlomo Staszewski; Bonaventura Clotet; Viktor von Wyl; Jens D Lundgren
The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitors.
AIDS (London, England) 2007;21(15):2033-42.
2007: Nicolai Lohse; Ann-Brit Eg Hansen; Jan Gerstoft; Niels Obel
Improved survival in HIV-infected persons: consequences and perspectives.
The Journal of antimicrobial chemotherapy 2007;60(3):461-3.
2007: Nicolai Lohse; Ann-Brit Eg Hansen; Gitte Pedersen; Gitte Kronborg; Jan Gerstoft; Henrik Toft Sørensen; Michael Vaeth; Niels Obel
[Survival in patients with HIV infection].
Ugeskrift for laeger 2007;169(26):2529-32.
2007: Niels Obel; Henrik F Thomsen; Gitte Kronborg; Carsten Schade Larsen; Per R Hildebrandt; Henrik T Sørensen; Jan Gerstoft
Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(12):1625-31.
2007: Mette Thorn; Sheila Tuyet Tang; Dominic Therrien; Henrik Kløverpris; Lasse Vinner; Gitte Kronborg; Jan Gerstoft; Sylvie Corbet; Anders Fomsgaard
Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2007;115(6):757-68.
2007: Tina V Madsen; Thomas Leitner; Nicolai Lohse; Niels Obel; Karin Ladefoged; Jan Gerstoft; Ann Berith Petersen; Claus Nielsen; Louise B Jørgensen
Introduction of HIV type 1 into an isolated population: molecular epidemiologic study from Greenland.
AIDS research and human retroviruses 2007;23(5):675-81.
2007: Anne-Mette Lebech; Niels Wiinberg; Ulrik Sloth Kristoffersen; Birger Hesse; Claus Leth Petersen; Jan Gerstoft; Andreas Kjaer
Carotid intima-media thickness in HIV patients treated with antiretroviral therapy.
Clinical physiology and functional imaging 2007;27(3):173-9.
2007: Line D Rasmussen; Jan Gerstoft; Gitte Kronborg; Carsten Schade Larsen; Gitte Pedersen; Niels Obel
Mortality after myocardial infarction in HIV-infected patients who have initiated HAART.
AIDS (London, England) 2007;21(7):873-5.
2007: Christian Erikstrup; Per Kallestrup; Rutendo Zinyama; Exnevia Gomo; Boniface Mudenge; Jan Gerstoft; Henrik Ullum
Predictors of mortality in a cohort of HIV-1-infected adults in rural Africa.
Journal of acquired immune deficiency syndromes (1999) 2007;44(4):478-83.
2007: Birgitte Lindegaard; L F Larsen; Ann-Brit Eg Hansen; Jan Gerstoft; Bente Klarlund Pedersen; K Reue
Adipose tissue lipin expression levels distinguish HIV patients with and without lipodystrophy.
International journal of obesity (2005) 2007;31(3):449-56.
2007: Martin Tolstrup; Joanna Selzer-Plön; Alex Lund Laursen; Lone Bertelsen; Jan Gerstoft; Mogens Duch; Finn Skou Pedersen; Lars Ostergaard
Full fusion competence rescue of the enfuvirtide resistant HIV-1 gp41 genotype (43D) by a prevalent polymorphism (137K).
AIDS (London, England) 2007;21(4):519-21.
2007: Nicolai Lohse; Ann-Brit Eg Hansen; Gitte Pedersen; Gitte Kronborg; Jan Gerstoft; Henrik Toft Sørensen; Michael Vaeth; Niels Obel
Survival of persons with and without HIV infection in Denmark, 1995-2005.
Annals of internal medicine 2007;146(2):87-95.
2007: Ann-Brit Eg Hansen; Jan Gerstoft; Gitte Kronborg; Court Pedersen; Henrik Toft Sorensen; Niels Obel
Mortality in siblings of patients coinfected with HIV and hepatitis C virus.
The Journal of infectious diseases 2007;195(2):230-5.
2007: Nicolai Lohse; Louise B Jørgensen; Gitte Kronborg; Axel Møller; Birgit Kvinesdal; Henrik T Sørensen; Niels Obel; Jan Gerstoft
Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failure.
Antiviral therapy 2007;12(6):909-17.
2007: Ann-Brit Eg Hansen; Nicolai Lohse; Jan Gerstoft; Gitte Kronborg; Alex Lund Laursen; Court Pedersen; Henrik Toft Sørensen; Niels Obel
Cause-specific excess mortality in siblings of patients co-infected with HIV and hepatitis C virus.
PloS one 2007;2(8):e738.
2007: Sofie Mathiesen; Elisabeth DAM; Birgit T Roge; Louise Bruun Joergensen; Alex Lund Laursen; Jan Gerstoft; François Clavel
Long-term foscarnet therapy remodels thymidine analogue mutations and alters resistance to zidovudine and lamivudine in HIV-1.
Antiviral therapy 2007;12(3):335-43.
2007: Helene Mens; Anders G Pedersen; Louise B Jørgensen; Stephane Hue; Yizi Yang; Jan Gerstoft; Terese L Katzenstein
Investigating signs of recent evolution in the pool of proviral HIV type 1 DNA during years of successful HAART.
AIDS research and human retroviruses 2007;23(1):107-15.
2006: Martin Tolstrup; Alex Lund Laursen; Jan Gerstoft; Finn Skou Pedersen; Lars Ostergaard; Mogens Duch
Cysteine 138 mutation in HIV-1 Nef from patients with delayed disease progression.
Sexual health 2006;3(4):281-6.
2006: Pedro Cahn; Jorge Villacian; Adriano Lazzarin; Christine Katlama; Beatriz Grinsztejn; Keikawus Arastéh; Paulo López; Nathan Clumeck; Jan Gerstoft; Nikolas Stavrianeas; Santiago Moreno; Francisco Antunes; Dietmar Neubacher; Douglas Mayers
Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients: 24-week results of the RESIST-2 trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(10):1347-56.
2006: Per Kallestrup; Rutendo Zinyama; Exnevia Gomo; Anthony Butterworth; Govert van Dam; Jan Gerstoft; Christian Erikstrup; Henrik Ullum
Schistosomiasis and HIV in rural Zimbabwe: efficacy of treatment of schistosomiasis in individuals with HIV coinfection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(12):1781-9.
2006: Rosa Ryt-Hansen; Terese L Katzenstein; Jan Gerstoft; Jesper Eugen-Olsen
No influence of GB virus C on disease progression in a Danish cohort of HIV-infected men.
AIDS research and human retroviruses 2006;22(6):496-8.
2006: Sisse R Ostrowski; Terese L Katzenstein; M Pedersen; Gunilla Høyer-Hansen; Jan Gerstoft; Bente Klarlund Pedersen; Henrik Ullum
Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy.
Scandinavian journal of immunology 2006;63(6):478-86.
2006: Andreas Kjaer; Anne-Mette Lebech; Jan Gerstoft; Birger Hesse; Claus Leth Petersen
Right ventricular volume and mass determined by cine magnetic resonance imaging in HIV patients with possible right ventricular dysfunction.
Angiology 2006;57(3):341-6.
2006: Kristian Kofoed; Jan Gerstoft; Lars Mathiesen; Thomas Benfield
Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response.
Sexually transmitted diseases 2006;33(3):143-8.
2006: Zoe Fox; Ulrik B Dragsted; Jan Gerstoft; Andrew N Phillips; Jesper Kjaer; Lars Mathiesen; Mike Youle; Christine Katlama; Andrew Hill; Johan Bruun; Nathan Clumeck; Pierre Dellamonica; Jens D Lundgren
A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial.
Antiviral therapy 2006;11(6):761-70.
2006: Toke S Barfod; Frederick Hecht; Cecilie Rubow; Jan Gerstoft
Physicians' communication with patients about adherence to HIV medication in San Francisco and Copenhagen: a qualitative study using Grounded Theory.
BMC health services research 2006;6():154.
2006: Nicolai Lohse; Niels Obel; Gitte Kronborg; Louise B Jørgensen; Court Pedersen; Carsten Schade Larsen; Birgit Kvinesdal; Henrik Toft Sørensen; Jan Gerstoft
Declining prevalence of HIV-infected individuals at risk of transmitting drug-resistant HIV in Denmark during 1997-2004.
Antiviral therapy 2006;11(5):591-600.
2006: Ase B Andersen; Ian Law; Sisse R Ostrowski; Anne-Mette Lebech; Gunilla Høyer-Hansen; Liselotte Højgaard; Jan Gerstoft; Henrik Ullum; Andreas Kjaer
Self-reported fatigue common among optimally treated HIV patients: no correlation with cerebral FDG-PET scanning abnormalities.
Neuroimmunomodulation 2006;13(2):69-75.
2006: Nicolai Lohse; Gitte Kronborg; Jan Gerstoft; Carsten Schade Larsen; Gitte Pedersen; Court Pedersen; Henrik Toft Sørensen; Niels Obel
Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(1):136-44.
2006: Ann-Brit Eg Hansen; Birgitte Lindegaard; Niels Obel; Ove Andersen; Henrik Nielsen; Jan Gerstoft
Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
HIV medicine 2006;7(1):38-45.
2005: Per Kallestrup; Rutendo Zinyama; Exnevia Gomo; Anthony Butterworth; Boniface Mudenge; Govert van Dam; Jan Gerstoft; Christian Erikstrup; Henrik Ullum
Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load.
The Journal of infectious diseases 2005;192(11):1956-61.
2005: Ulrik S Justesen; I M Hansen; A B Andersen; Niels A Klitgaard; FT Black; Jan Gerstoft; Lars Mathiesen; Court Pedersen
The long-term pharmacokinetics and safety of adding low-dose ritonavir to a nelfinavir 1,250 mg twice-daily regimen in HIV-infected patients.
HIV medicine 2005;6(5):334-40.
2005: Sisse R Ostrowski; Henrik Ullum; Bente Klarlund Pedersen; Jan Gerstoft; Terese L Katzenstein
2B4 expression on natural killer cells increases in HIV-1 infected patients followed prospectively during highly active antiretroviral therapy.
Clinical and experimental immunology 2005;141(3):526-33.
2005: Nicolai Lohse; Niels Obel; Gitte Kronborg; Alex Lund Laursen; Court Pedersen; Carsten Schade Larsen; Birgit Kvinesdal; Henrik Toft Sørensen; Jan Gerstoft
Declining risk of triple-class antiretroviral drug failure in Danish HIV-infected individuals.
AIDS (London, England) 2005;19(8):815-22.
2005: Toke S Barfod; Jan Gerstoft; Lotte Rodkjaer; Court Pedersen; Henrik Nielsen; Aksel Møller; Lena Hagelskjaer Kristensen; Henrik T Sørensen; Niels Obel; Lena Hagelskajaer Kristensen
Patients' answers to simple questions about treatment satisfaction and adherence and depression are associated with failure of HAART: a cross-sectional survey.
AIDS patient care and STDs 2005;19(5):317-25.
2005: Sisse R Ostrowski; Timo Piironen; Gunilla Høyer-Hansen; Jan Gerstoft; Bente Klarlund Pedersen; Henrik Ullum
High plasma levels of intact and cleaved soluble urokinase receptor reflect immune activation and are independent predictors of mortality in HIV-1-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2005;39(1):23-31.
2005: Sisse R Ostrowski; Timo Piironen; Gunilla Høyer-Hansen; Jan Gerstoft; Bente Klarlund Pedersen; Henrik Ullum
Reduced release of intact and cleaved urokinase receptor in stimulated whole-blood cultures from human immunodeficiency virus-1-infected patients.
Scandinavian journal of immunology 2005;61(4):347-56.
2005: Sisse R Ostrowski; Terese L Katzenstein; Per T Thim; Bente Klarlund Pedersen; Jan Gerstoft; Henrik Ullum
Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy.
The Journal of infectious diseases 2005;191(3):348-57.
2005: Ulrik B Dragsted; Jan Gerstoft; Mike Youle; Zoe Fox; Marcelo H Losso; Jorge Benetucci; Dushyantha Jayaweera; Armin Rieger; Johan Bruun; Antonella Castagna; Brian Gazzard; Sharon Walmsley; Andrew Hill; Jens D Lundgren
A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial.
Antiviral therapy 2005;10(6):735-43.
2004: Astrid K N Iversen; Jørn Attermann; Jan Gerstoft; Lars Fugger; James I Mullins; Peter Skinhøj
Longitudinal and cross-sectional studies of HIV-1 RNA and DNA loads in blood and the female genital tract.
European journal of obstetrics, gynecology, and reproductive biology 2004;117(2):227-35.
2004: Jan Gerstoft
[Enfuvirtide].
Ugeskrift for laeger 2004;166(48):4355-7.
2004: Per Kallestrup; Rutendo Zinyama; Exnevia Gomo; Jan Gerstoft; Henrik Ullum
HIV in Africa - still a major matter of unsafe sex.
International journal of STD & AIDS 2004;15(10):709-10; author reply 710-1.
2004: Edwin DeJesus; Gisela Herrera; Eugenio Teofilo; Jan Gerstoft; Carlos Beltran Buendia; J David Brand; Cindy H Brothers; Jaime Hernandez; Steve A Castillo; Tab Bonny; E Randall Lanier; Trevor R Scott
Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(7):1038-46.
2004: Birgitte Lindegaard; Ann-Brit Eg Hansen; Henriette Pilegaard; Pernille Keller; Jan Gerstoft; Bente Klarlund Pedersen
Adipose tissue expression of IL-18 and HIV-associated lipodystrophy.
AIDS (London, England) 2004;18(14):1956-8.
2004: Birgit T Røge; Toke S Barfod; Ole Kirk; Terese L Katzenstein; Niels Obel; Henrik Nielsen; Court Pedersen; Lars Mathiesen; Jens D Lundgren; Jan Gerstoft
Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study.
HIV medicine 2004;5(5):344-51.
2004: Birgitte Lindegaard; Ann-Brit Eg Hansen; Jan Gerstoft; Bente Klarlund Pedersen
High plasma level of interleukin-18 in HIV-infected subjects with lipodystrophy.
Journal of acquired immune deficiency syndromes (1999) 2004;36(1):588-93.
2004: Sofie Mathiesen; Birgit T Roge; Nina Weis; Jens D Lundgren; Niels Obel; Jan Gerstoft
Foscarnet used in salvage therapy of HIV-1 patients harbouring multiple nucleotide excision mutations.
AIDS (London, England) 2004;18(7):1076-8.
2004: Sisse R Ostrowski; Terese L Katzenstein; Timo Piironen; Jan Gerstoft; Bente Klarlund Pedersen; Henrik Ullum
Soluble urokinase receptor levels in plasma during 5 years of highly active antiretroviral therapy in HIV-1-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2004;35(4):337-42.
2004: Anne-Mette Lebech; Jan Gerstoft; Birger Hesse; Claus Leth Petersen; Andreas Kjaer
Right and left ventricular cardiac function in a developed world population with human immunodeficiency virus studied with radionuclide ventriculography.
American heart journal 2004;147(3):482-8.
2004: Birgitte Lindegaard; Pernille Keller; Helle Bruunsgaard; Jan Gerstoft; Bente Klarlund Pedersen
Low plasma level of adiponectin is associated with stavudine treatment and lipodystrophy in HIV-infected patients.
Clinical and experimental immunology 2004;135(2):273-9.
2004: Ulrik S Justesen; A B Andersen; Niels A Klitgaard; Kim Brøsen; Jan Gerstoft; Court Pedersen
Pharmacokinetic interaction between rifampin and the combination of indinavir and low-dose ritonavir in HIV-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(3):426-9.
2004: Ann-Brit Eg Hansen; Sofie Mathiesen; Jan Gerstoft
Severe metabolic acidosis and renal failure in an HIV-1 patient receiving tenofovir.
Scandinavian journal of infectious diseases 2004;36(5):389-92.
2004: Anne Lerbaek; Thomas Birk kristiansen; Terese L Katzenstein; Lars Mathiesen; Jan Gerstoft; Claus Nielsen; Klaus Larsen; Jens Ole Nielsen; Niels Obel; Alex Lund Laursen; Susanne D Nielsen
Tenofovir treatment in an unselected cohort of highly antiretroviral experienced HIV positive patients.
Scandinavian journal of infectious diseases 2004;36(4):280-6.
2003: Ole Kirk; Jens D Lundgren; Court Pedersen; Lars Mathiesen; Henrik Nielsen; Terese L Katzenstein; Niels Obel; Jan Gerstoft
A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors.
Antiviral therapy 2003;8(6):595-602.
2003: Peter Humaidan; Inge Agerholm; Hans Jakob Ingerslev; Court Pedersen; Jan Gerstoft; Anders Nyboe Andersen
[Artificial fertilization and HIV-positive couples--a risk-reducing treatment].
Ugeskrift for laeger 2003;165(48):4632-5.
2003: Jan Gerstoft; Ole Kirk; Niels Obel; Court Pedersen; Lars Mathiesen; Henrik Nielsen; Terese L Katzenstein; Jens D Lundgren
Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.
AIDS (London, England) 2003;17(14):2045-52.
2003: Jan Gerstoft; Peter Skinhøj
[Post-exposure prophylaxis against HIV].
Ugeskrift for laeger 2003;165(39):3707.
2003: Ulrik B Dragsted; Jan Gerstoft; Court Pedersen; Barry Peters; Adriana Duran; Niels Obel; Antonella Castagna; Pedro Cahn; Nathan Clumeck; Johan Bruun; Jorge Benetucci; Andrew Hill; Isabel Cassetti; Pietro Vernazza; Mike Youle; Zoe Fox; Jens D Lundgren
Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial.
The Journal of infectious diseases 2003;188(5):635-42.
2003: Per Kallestrup; Rutendo Zinyama; Exnevia Gomo; Ebbe Dickmeiss; Per Platz; Jan Gerstoft; Henrik Ullum
Low prevalence of hepatitis C virus antibodies in HIV-endemic area of Zimbabwe support sexual transmission as the major route of HIV transmission in Africa.
AIDS (London, England) 2003;17(9):1400-2.
2003: Sisse R Ostrowski; Jan Gerstoft; Bente Klarlund Pedersen; Henrik Ullum
A low level of CD4+CD28+ T cells is an independent predictor of high mortality in human immunodeficiency virus type 1-infected patients.
The Journal of infectious diseases 2003;187(11):1726-34.
2003: Jan Gerstoft; Peter Skinhøj
[SARS. Severe acute respiratory syndrome].
Ugeskrift for laeger 2003;165(19):1967-70.
2003: H Aladdin; Terese L Katzenstein; A-M Dreves; L Ryder; Jan Gerstoft; Peter Skinhøj; Bente Klarlund Pedersen; Henrik Ullum
T-cell receptor excisional circles, telomere length, proliferation and apoptosis in peripheral blood mononuclear cells of human immunodeficiency virus-infected individuals after 18 months of treatment induced viral suppression.
Scandinavian journal of immunology 2003;57(5):485-92.
2003: Juan A Arnaiz; Josep Mallolas; Daniel Podzamczer; Jan Gerstoft; Jens D Lundgren; Pedro Cahn; Gerd Fätkenheuer; Antonella d'Arminio Monforte; Arnaldo Casiró; Peter Reiss; David Burger; Michael Stek; José M Gatell
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load.
AIDS (London, England) 2003;17(6):831-40.
2003: Birgit T Røge; Terese L Katzenstein; Niels Obel; Henrik Nielsen; Ole Kirk; Court Pedersen; Lars Mathiesen; Jens Lundgren; Jan Gerstoft
K65R with and without S68: a new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudine.
Antiviral therapy 2003;8(2):173-82.
2003: Hans R Lüttichau; Ian Clark-Lewis; Peter Østrup Jensen; Claus Moser; Jan Gerstoft; Thue W Schwartz
A highly selective CCR2 chemokine agonist encoded by human herpesvirus 6.
The Journal of biological chemistry 2003;278(13):10928-33.
2003: Sisse R Ostrowski; Jan Gerstoft; Bente Klarlund Pedersen; Henrik Ullum
Impaired production of cytokines is an independent predictor of mortality in HIV-1-infected patients.
AIDS (London, England) 2003;17(4):521-30.
2003: Astrid K N Iversen; Claus Bohn Christiansen; Jørn Attermann; Jesper Eugen-Olsen; Sam Schulman; Erik Berntorp; Jørgen Ingerslev; Lars Fugger; Elma Scheibel; Lilian Tengborn; Jan Gerstoft; Ebbe Dickmeiss; Arne Svejgaard; Peter Skinhøj
Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus.
The Journal of infectious diseases 2003;187(2):215-25.
2003: Louise B Jørgensen; Marianne B Christensen; Jan Gerstoft; Lars Mathiesen; Niels Obel; Court Pedersen; Henrik Nielsen; Claus Nielsen
Prevalence of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark.
Scandinavian journal of infectious diseases 2003;35(11-12):800-7.
2003: Tuan K Huynh; Hans R Lüttichau; Birgit T Roge; Jan Gerstoft
Natural history of hyperlactataemia in human immunodeficiency virus-1-infected patients during highly active antiretroviral therapy.
Scandinavian journal of infectious diseases 2003;35(1):62-6.
2003: Terese L Katzenstein; Henrik Ullum; Birgit T Røge; JH Wandall; Ebbe Dickmeiss; T Barrington; Peter Skinhøj; Jan Gerstoft
Virological and immunological profiles among patients with undetectable viral load followed prospectively for 24 months.
HIV medicine 2003;4(1):53-61.
2003: Birgit T Røge; Terese L Katzenstein; H L Nielsen; Jan Gerstoft
Drug resistance mutations and outcome of second-line treatment in patients with first-line protease inhibitor failure on nelfinavir-containing HAART.
HIV medicine 2003;4(1):38-47.
2002: Jan Gerstoft
[Prion diseases].
Ugeskrift for laeger 2002;164(50):5901-2.
2002: D Worm; Ole Kirk; Ove Andersen; Jørgen Vinten; Jan Gerstoft; Terese L Katzenstein; Henrik Nielsen; Court Pedersen
Clinical lipoatrophy in HIV-1 patients on HAART is not associated with increased abdominal girth, hyperlipidaemia or glucose intolerance.
HIV medicine 2002;3(4):239-46.
2002: Ole Kirk; Peter Reiss; Caterina Uberti-Foppa; Markus Bickel; Jan Gerstoft; Christian Pradier; Ferdinand W N M Wit; bruno ledergerber; Jens D Lundgren; Hansjakob Furrer
Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy.
Annals of internal medicine 2002;137(4):239-50.
2002: Jørn Carlsen; Keld Kjeldsen; Jan Gerstoft
Sildenafil as a successful treatment of otherwise fatal HIV-related pulmonary hypertension.
AIDS (London, England) 2002;16(11):1568-9.
2002: Birgit T Røge; J A L Calbet; Kirsten Møller; Henrik Ullum; Helle W Hendel; Jan Gerstoft; Bente Klarlund Pedersen
Skeletal muscle mitochondrial function and exercise capacity in HIV-infected patients with lipodystrophy and elevated p-lactate levels.
AIDS (London, England) 2002;16(7):973-82.
2002: Terese L Katzenstein; Roberto S Oliveri; Thomas Benfield; Jesper Eugen-Olsen; Claus Nielsen; Jan Gerstoft
Cell-associated HIV DNA measured early during infection has prognostic value independent of serum HIV RNA measured concomitantly.
Scandinavian journal of infectious diseases 2002;34(7):529-33.
2002: Ebbe Dickmeiss; Jan Gerstoft
Blood infectivity in transmissible spongiform encephalopathies.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2002;110(1):99-103.
2001: H Aladdin; M Von Essen; Peter Schjerling; Terese L Katzenstein; Jan Gerstoft; Peter Skinhøj; Bente Klarlund Pedersen; Henrik Ullum
T-cell mean telomere lengths changes in treatment naïve HIV-infected patients randomized to G-CSF or placebo simultaneously with initiation of HAART.
Scandinavian journal of immunology 2001;54(3):301-5.
2001: Hans R Lüttichau; Jan Gerstoft; Thue W Schwartz
MC148 encoded by human molluscum contagiosum poxvirus is an antagonist for human but not murine CCR8.
Journal of leukocyte biology 2001;70(2):277-82.
2001: Terese L Katzenstein; Ebbe Dickmeiss; H Aladdin; A Hede; C Nielsen; Henrik Nielsen; Louise B Jørgensen; Jan Gerstoft
[No development of HIV infection after transfusion with HIV-contaminated blood and postexposure antiviral prevention].
Ugeskrift for laeger 2001;163(19):2635-7.
2001: Jan Gerstoft
[Influenza vaccination of healthy adults].
Ugeskrift for laeger 2001;163(19):2615-7.
2001: Hans R Lüttichau; I C Lewis; Jan Gerstoft; Thue W Schwartz
The herpesvirus 8-encoded chemokine vMIP-II, but not the poxvirus-encoded chemokine MC148, inhibits the CCR10 receptor.
European journal of immunology 2001;31(4):1217-20.
2001: Søren Jensen-Fangel; Ole Kirk; Anders Blaxhult; Jan Gerstoft; Court Pedersen; FT Black; J D Lundgren; Niels Obel
The insufficient suppression of viral load by saquinavir hard gel is reversible: a retrospective cohort study.
HIV clinical trials 2001;2(2):122-7.
2001: H Aladdin; Carsten Schade Larsen; Peter Schjerling; Bjarne Møller; MR Buhl; Jan Gerstoft; Bente Klarlund Pedersen; Henrik Ullum
Effects of subcutaneous IL-2 therapy on telomere lengths in PBMC in HIV-infected patients.
Scandinavian journal of immunology 2001;53(3):315-9.
2001: C Espersen; B Pakkenberg; E Harder; G Pallesen; Jan Gerstoft; Bente Klarlund Pedersen; Henrik Ullum
High levels of CD8-positive lymphocytes expressing CD45R0, granzyme B, and Ki-67 in lymph nodes of HIV-infected individuals are not associated with increased mortality.
AIDS research and human retroviruses 2001;17(4):287-93.
2001: M Bøgh; R Machuca; Jan Gerstoft; Court Pedersen; Niels Obel; Birgit Kvinesdal; Henrik Nielsen; Claus Nielsen
Subtype-specific problems with qualitative Amplicor HIV-1 DNA PCR test.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2001;20(3):149-53.
2001: Ole Kirk; Jan Gerstoft; Court Pedersen; Henrik Nielsen; Niels Obel; Terese L Katzenstein; Lars Mathiesen; Jens D Lundgren
Low body weight and type of protease inhibitor predict discontinuation and treatment-limiting adverse drug reactions among HIV-infected patients starting a protease inhibitor regimen: consistent results from a randomized trial and an observational cohort.
HIV medicine 2001;2(1):43-51.
2001: R Machuca; M Bøgh; M Salminen; Jan Gerstoft; Birgit Kvinesdal; Court Pedersen; Niels Obel; Henrik Nielsen; Claus Nielsen
HIV-1 subtypes in Denmark.
Scandinavian journal of infectious diseases 2001;33(9):697-701.
2001: Birgit T Røge; Terese L Katzenstein; Jan Gerstoft
Comparison of P-triglyceride levels among patients with human immunodeficiency virus on randomized treatment with ritonavir, indinavir or ritonavir/saquinavir.
Scandinavian journal of infectious diseases 2001;33(4):306-11.
2000: Louise B Jørgensen; Terese L Katzenstein; Jan Gerstoft; Lars Mathiesen; Court Pedersen; Claus Nielsen
Genotypic and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine.
Antiviral therapy 2000;5(3):187-94.
2000: Susanne D Nielsen; TU Sørensen; H Aladdin; Annette K Ersbøll; Lars Mathiesen; Henrik Ullum; Jan Gerstoft; Jens Ole Nielsen; Bente Klarlund Pedersen
The effect of long-term treatment with granulocyte colony-stimulating factor on hematopoiesis in HIV-infected individuals.
Scandinavian journal of immunology 2000;52(3):298-303.
2000: Terese L Katzenstein; Ole Kirk; Court Pedersen; Jens D Lundgren; Henrik Nielsen; Niels Obel; Claus Nielsen; Lars Mathiesen; Jan Gerstoft
The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 2000;182(3):744-50.
2000: Jan Gerstoft
[Transmission of bovine spongiform encephalopathy prions to human].
Ugeskrift for laeger 2000;162(34):4515-7.
2000: H Aladdin; Henrik Ullum; Peter Schjerling; M Skov Jensen; S Dam Nielsen; Lars Mathiesen; Jan Gerstoft; Peter Skinhøj; Bente Klarlund Pedersen
Effects of G-CSF on telomere lengths in PBMCs from human immunodeficiency virus-infected patients: results from a randomized, placebo-controlled trial.
Scandinavian journal of immunology 2000;52(2):212-6.
2000: Terese L Katzenstein; Ebbe Dickmeiss; H Aladdin; A Hede; Claus Nielsen; Henrik Nielsen; Louise B Jørgensen; Jan Gerstoft
Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis.
Annals of internal medicine 2000;133(1):31-4.
2000: H Aladdin; Henrik Ullum; Terese L Katzenstein; Jan Gerstoft; Peter Skinhøj; Bente Klarlund Pedersen
Immunological and virological changes in antiretroviral naïve human immunodeficiency virus infected patients randomized to G-CSF or placebo simultaneously with initiation of HAART.
Scandinavian journal of immunology 2000;51(5):520-5.
2000: H Aladdin; Henrik Ullum; S Dam Nielsen; C Espersen; Lars Mathiesen; Terese L Katzenstein; Jan Gerstoft; P Skinhoj; Bente Klarlund Pedersen
Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo-controlled trial.
The Journal of infectious diseases 2000;181(3):1148-52.
2000: Jan Gerstoft
[Influenza--drug therapy and prevention].
Ugeskrift for laeger 2000;162(6):767-70.
2000: H Aladdin; Carsten Schade Larsen; Bjarne Møller; Henrik Ullum; MR Buhl; Jan Gerstoft; Peter Skinhøj; Bente Klarlund Pedersen
Effects of subcutaneous interleukin-2 therapy on phenotype and function of peripheral blood mononuclear cells in human immunodeficiency virus infected patients.
Scandinavian journal of immunology 2000;51(2):168-75.
2000: Hans R Lüttichau; JT Stine; Thomas P Boesen; Anders H Johnsen; D Chantry; Jan Gerstoft; Thue W Schwartz
A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum.
The Journal of experimental medicine 2000;191(1):171-80.
2000: Henrik Ullum; AC Lepri; Terese L Katzenstein; AN Phillips; Peter Skinhøj; Jan Gerstoft; Bente Klarlund Pedersen
Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels.
Scandinavian journal of infectious diseases 2000;32(4):371-6.
2000: SR Søndergaard; Alessandro Cozzi-Lepri; Henrik Ullum; Jørgen Wiis; C K Hermann; S B Laursen; Jesper Qvist; Jan Gerstoft; Peter Skinhøj; Bente Klarlund Pedersen
Adrenaline-induced mobilization of T cells in HIV-infected patients.
Clinical and experimental immunology 2000;119(1):115-22.
1999: Astrid K N Iversen; Gerald Learn; Lars Fugger; Jan Gerstoft; James I Mullins; P Skinhoj
Presence of multiple HIV subtypes and a high frequency of subtype chimeric viruses in heterosexually infected women.
Journal of acquired immune deficiency syndromes (1999) 1999;22(4):325-32.
1999: K M Madsen; Jan Gerstoft; Birgit Kvinesdal; Henrik I Nielsen; A Møller; Court Pedersen; Niels Obel
[Use of antiretroviral chemoprophylaxis after occupational HIV exposure].
Ugeskrift for laeger 1999;161(48):6619-21.
1999: Terese L Katzenstein; Louise B Jørgensen; H Permin; J Hansen; Claus Nielsen; R Machuca; Jan Gerstoft
Nosocomial HIV-transmission in an outpatient clinic detected by epidemiological and phylogenetic analyses.
AIDS (London, England) 1999;13(13):1737-44.
1999: Ole Kirk; Jens D Lundgren; Court Pedersen; Henrik Nielsen; Jan Gerstoft
Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?
AIDS (London, England) 1999;13(13):1647-51.
1999: SR Søndergaard; H Aladdin; Henrik Ullum; Jan Gerstoft; Peter Skinhøj; Bente Klarlund Pedersen
Immune function and phenotype before and after highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 1999;21(5):376-83.
1999: H Aladdin; Henrik Ullum; AC Lepri; H Leffers; Terese L Katzenstein; Jan Gerstoft; SB Gjedde; AN Phillips; Peter Skinhøj; Bente Klarlund Pedersen
Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of death.
Scandinavian journal of immunology 1999;50(2):223-7.
1999: Peter Skinhøj; Jan Gerstoft
[Treatment of bacterial gastroenteritis].
Ugeskrift for laeger 1999;161(19):2801-3.
1999: Henrik Ullum; Terese L Katzenstein; H Aladdin; Claus Nielsen; S R Sondergaard; Jan Gerstoft; P Skinhoj; Bente Klarlund Pedersen
Immunological changes in human immunodeficiency virus (HIV)-infected individuals during HIV-specific protease inhibitor treatment.
Scandinavian journal of immunology 1999;49(5):539-47.
1999: Henrik Ullum; Alessandro Cozzi-Lepri; H Aladdin; Terese L Katzenstein; J Victor; AN Phillips; Jan Gerstoft; Peter Skinhøj; Bente Klarlund Pedersen
Natural immunity and HIV disease progression.
AIDS (London, England) 1999;13(5):557-63.
1999: Ole Kirk; Terese L Katzenstein; Jan Gerstoft; Lars Mathiesen; Henrik Nielsen; Court Pedersen; Jens D Lundgren
Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial.
AIDS (London, England) 1999;13(1):F9-16.
1999: Søren Jensen-Fangel; Ole Kirk; L Larsen; Anders Blaxhult; Jan Gerstoft; Court Pedersen; FT Black; J D Lundgren; Niels Obel
Saquinavir hard gel suppresses viral load insufficiently in HIV-infected patients naive to anti-retroviral therapy: a retrospective cohort study.
Scandinavian journal of infectious diseases 1999;31(5):489-93.
1998: Bodil Laub Petersen; Christian Buchwald; Jan Gerstoft; Poul Bretlau; H Lindeberg
An aggressive and invasive growth of juvenile papillomas involving the total respiratory tract.
The Journal of laryngology and otology 1998;112(11):1101-4.
1998: Astrid K N Iversen; Lars Fugger; Jesper Eugen-Olsen; Ulla Balslev; T Jensen; S Wahl; Jan Gerstoft; James I Mullins; P Skinhoj
Cervical human immunodeficiency virus type 1 shedding is associated with genital beta-chemokine secretion.
The Journal of infectious diseases 1998;178(5):1334-42.
1998: PH Jakobsen; KK Dodt; C N Meyer; Terese L Katzenstein; Jan Gerstoft; Peter Skinhøj
Increased levels of soluble tumour necrosis factor receptor-I (P55) and decreased IgG1 reactivities in HIV-1 patients with cytomegalovirus disease.
Scandinavian journal of immunology 1998;47(6):591-5.
1998: Astrid K N Iversen; Anders Rhod Larsen; T Jensen; Lars Fugger; Ulla Balslev; S Wahl; Jan Gerstoft; James I Mullins; Peter Skinhøj
Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions.
The Journal of infectious diseases 1998;177(5):1214-20.
1998: Court Pedersen; Jan Gerstoft
[Antiviral prophylaxis and treatment of influenza].
Ugeskrift for laeger 1998;160(11):1615-7.
1998: Henrik Ullum; Alessandro Cozzi-Lepri; J Victor; H Aladdin; AN Phillips; Jan Gerstoft; Peter Skinhøj; Bente Klarlund Pedersen
Production of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1beta are associated with a decreased risk of HIV disease progression.
The Journal of infectious diseases 1998;177(2):331-6.
1998: Jan Gerstoft
[Stavudine and lamivudine. Two new nucleoside analogues efficient against HIV].
Ugeskrift for laeger 1998;160(4):457-61.
1997: Terese L Katzenstein; Court Pedersen; Jan Gerstoft
[HIV quantification--how and why].
Ugeskrift for laeger 1997;160(1):18-24.
1997: Court Pedersen; Jan Gerstoft
[Antiviral combination therapy against HIV].
Ugeskrift for laeger 1997;159(45):6655-9.
1997: Court Pedersen; T Katzenstein; C Nielsen; J D Lundgren; Jan Gerstoft
Prognostic value of serum HIV-RNA levels at virologic steady state after seroconversion: relation to CD4 cell count and clinical course of primary infection.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16(2):93-9.
1997: Thomas N Kledal; Mette M Rosenkilde; F Coulin; G Simmons; Anders H Johnsen; Sami Alouani; Christine A Power; Hans R Lüttichau; Jan Gerstoft; Paul R Clapham; Ian Clark-Lewis; Timothy Wells; Thue W Schwartz
A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus.
Science (New York, N.Y.) 1997;277(5332):1656-9.
1997: Terese L Katzenstein; Jesper Eugen-Olsen; B Hofmann; Thomas Benfield; Court Pedersen; Astrid K N Iversen; A M Sørensen; Peter Garred; Uffe Koppelhus; Arne Svejgaard; Jan Gerstoft
HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16(1):10-4.
1997: Henrik Ullum; J Victor; Terese L Katzenstein; Jan Gerstoft; P C Gøtzsche; Klaus Bendtzen; Peter Skinhøj; Bente Klarlund Pedersen
Decreased short-term production of tumor necrosis factor-alpha and interleukin-1beta in human immunodeficiency virus-seropositive subjects.
The Journal of infectious diseases 1997;175(6):1507-10.
1997: Jan Gerstoft
[Systemic antiviral chemotherapy].
Ugeskrift for laeger 1997;159(15):2197-200.
1997: Jesper Eugen-Olsen; Astrid K N Iversen; Peter Garred; Uffe Koppelhus; Court Pedersen; Thomas Benfield; A M Sorensen; Terese L Katzenstein; Ebbe Dickmeiss; Jan Gerstoft; Peter Skinhøj; Arne Svejgaard; Jens Ole Nielsen; B Hofmann
Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals.
AIDS (London, England) 1997;11(3):305-10.
1997: Henrik Ullum; Terese L Katzenstein; Jan Gerstoft; Peter Skinhøj; Bente Klarlund Pedersen
Increased plasma HIV type 1 RNA levels are associated with low levels of non-MHC class I-restricted cytotoxicity.
AIDS research and human retroviruses 1997;13(3):217-8.
1997: Peter Garred; Hans O Madsen; Ulla Balslev; B Hofmann; Court Pedersen; Jan Gerstoft; Arne Svejgaard
Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin.
Lancet 1997;349(9047):236-40.
1997: Jan Gerstoft; H Melander; Johan Bruun; C Pedersen; P C Głtzsche; O Berglund; Lars Mathiesen; P Skinhłj; S R Norrby
Alternating treatment with didanosine and zidovudine versus either drug alone for the treatment of advanced HIV infection. The Alter Study. Nordic HIV Therapy Group.
Scandinavian journal of infectious diseases 1997;29(2):121-8.
1996: Terese L Katzenstein; Claus Nielsen; L Bruun; L R Mathiesen; Court Pedersen; Jan Gerstoft
Quantification of HIV-1 RNA during antiretroviral therapy: association with viral phenotype and development of resistance.
Antiviral therapy 1996;1(4):246-54.
1996: Claus Nielsen; L Bruun; L R Mathiesen; Court Pedersen; Jan Gerstoft
Development of resistance of zidovudine (ZDV) and didanosine (ddI) in HIV from patients in ZDV, ddI and alternating ZDV/ddI therapy.
AIDS (London, England) 1996;10(6):625-33.
1996: Terese L Katzenstein; Court Pedersen; Claus Nielsen; J D Lundgren; P H Jakobsen; Jan Gerstoft
Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome.
AIDS (London, England) 1996;10(2):167-73.
1996: Terese L Katzenstein; Jan Gerstoft; Henrik Nielsen
Assessments of plasma HIV RNA and CD4 cell counts after combined Pneumovax and tetanus toxoid vaccination: no detectable increase in HIV replication 6 weeks after immunization.
Scandinavian journal of infectious diseases 1996;28(3):239-41.
1995: Jens D Lundgren; Court Pedersen; K D Bentsen; Jan Gerstoft; T Seefeldt-Nielsen; TL Nielsen; G F Jensen
[AIDS in Denmark. 2. Survival after the diagnosis of AIDS. Danish Study Group for HIV infection].
Ugeskrift for laeger 1995;157(10):1352-6.
1995: Jens D Lundgren; K D Bentsen; Court Pedersen; Jan Gerstoft; T Seefeldt-Nielsen; TL Nielsen; G F Jensen
[AIDS in Denmark. 1. Opportunistic infections and malignant diseases. Danish Study Group for HIV infection].
Ugeskrift for laeger 1995;157(10):1347-51.
1994: S Thorsen; Court Pedersen; Eric Sandström; C S Petersen; G Norkrans; Jan Gerstoft; A Karlsson; K C Christensen; C Håkansson; P O Pehrson
[Controlled, clinical trial of isoprinosine administration to HIV-infected patients. Results of a Danish/Swedish multicenter study. The Scandinavian Isoprinosine Study Group].
Ugeskrift for laeger 1994;156(22):3314-8.
1994: Peter C Gøtzsche; Claus Nielsen; Jan Gerstoft; C M Nielsen; B F Vestergaard
[Survival of patients with zidovudine resistant HIV].
Ugeskrift for laeger 1994;156(2):185-6.
1993: Claus Nielsen; Court Pedersen; J D Lundgren; Jan Gerstoft
Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection.
AIDS (London, England) 1993;7(8):1035-40.
1992: S Thorsen; Court Pedersen; Eric Sandström; C S Petersen; G Norkrans; Jan Gerstoft; A Karlsson; K C Christensen; C Håkansson; P O Pehrson
One-year follow-up on the safety and efficacy of isoprinosine for human immunodeficiency virus infection. Scandinavian Isoprinosine Study Group.
Journal of internal medicine 1992;231(6):607-15.
1992: Claus Nielsen; Peter C Gøtzsche; C M Nielsen; Jan Gerstoft; B F Vestergaard
Development of resistance to zidovudine in HIV strains isolated from CD4+ lymphocytes and plasma during therapy.
Antiviral research 1992;18(3-4):303-16.
1992: TL Nielsen; J K Eeftinck Schattenkerk; B N Jensen; Jens D Lundgren; Jan Gerstoft; RP van Steenwijk; K Bentsen; P H Frissen; J Gaub; M Orholm
Adjunctive corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS: a randomized European multicenter open label study.
Journal of acquired immune deficiency syndromes 1992;5(7):726-31.
1992: Peter C Gøtzsche; Claus Nielsen; Jan Gerstoft; C M Nielsen; B F Vestergaard
Trend towards decreased survival in patients infected with HIV resistant to zidovudine.
Scandinavian journal of infectious diseases 1992;24(5):563-5.
1991: B N Jensen; Jan Gerstoft; Peter Skinhøj
The prognosis in HIV-infected patients with pneumonia. Relation to microbiological diagnoses.
Danish medical bulletin 1991;38(6):468-70.
1991: B N Jensen; I M Lisse; Jan Gerstoft; S Borgeskov; Peter Skinhøj
Cellular profiles in bronchoalveolar lavage fluid of HIV-infected patients with pulmonary symptoms: relation to diagnosis and prognosis.
AIDS (London, England) 1991;5(5):527-33.
1991: Court Pedersen; Jan Gerstoft; J D Lundgren; P Skinhøj; J Bøttzauw; C Geisler; S J Hamilton-Dutoit; S Thorsen; I Lisse; E Ralfkiaer
HIV-associated lymphoma: histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features.
European journal of cancer (Oxford, England : 1990) 1991;27(11):1416-23.
1990: Bente Klarlund Pedersen; N Tvede; M Diamant; Jan Gerstoft; M Bagge Hansen; P M Haahr; M Hørding; M Kappel; Mads Klokker; B Søeberg
Effects of isoprinosine treatment of HIV-positive patients on blood mononuclear cell subsets, NK- and T-cell function, tumour necrosis factor, and interleukins 1, 2, and 6.
Scandinavian journal of immunology 1990;32(6):641-9.
1990: E Smith; S Kroon; Jan Gerstoft; B B Kvinesdal; L R Mathiesen
[HIV infected women in Copenhagen. Risk factors and sex behavior].
Ugeskrift for laeger 1990;152(48):3603-6.
1990: E Smith; S Kroon; Jan Gerstoft; B Kvinesdal; L R Mathiesen
Heterosexually acquired human immunodeficiency virus infection in women in Copenhagen: sexual behavior and other risk factors.
International journal of STD & AIDS 1990;1(6):416-21.
1990: Court Pedersen; Jan Gerstoft; P Tauris; Jens D Lundgren; Peter C Gøtzsche; M Buhl; Y Salim; K Schmidt; Jens Ole Nielsen
Trends in survival of Danish AIDS patients from 1981 to 1989.
AIDS (London, England) 1990;4(11):1111-6.
1990: Court Pedersen; Eric Sandström; C S Petersen; G Norkrans; Jan Gerstoft; A Karlsson; K C Christensen; C Håkansson; P O Pehrson; J O Nielsen
The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group.
The New England journal of medicine 1990;322(25):1757-63.
1990: Court Pedersen; Jan Gerstoft; P Tauris; Jens D Lundgren; Peter C Gøtzsche; M Buhl; Y Salim; K Schmidt
Opportunistic infections and malignancies in 231 Danish AIDS patients.
AIDS (London, England) 1990;4(3):233-8.
1990: B N Jensen; Jan Gerstoft; Niels Højlyng; Vibeke Backer; M Paaske; G Gomme; Peter Skinhøj
Pulmonary pathogens in HIV-infected patients.
Scandinavian journal of infectious diseases 1990;22(4):413-20.
1989: Court Pedersen; B O Lindhardt; B L Jensen; E Lauritzen; Jan Gerstoft; Ebbe Dickmeiss; J Gaub; E Scheibel; T Karlsmark
Clinical course of primary HIV infection: consequences for subsequent course of infection.
BMJ (Clinical research ed.) 1989;299(6692):154-7.
1989: B O Lindhardt; Jan Gerstoft; B Hofmann; G Pallesen; Lars Mathiesen; Ebbe Dickmeiss; K Ulrich
Antibodies against the major core protein p24 of human immunodeficiency virus: relation to immunological, clinical and prognostic findings.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(7):614-9.
1989: Court Pedersen; P Kolby; J Sindrup; J Gaub; S Ullman; Jan Gerstoft; B O Lindhardt; Ebbe Dickmeiss
The development of AIDS or AIDS-related conditions in a cohort of HIV antibody-positive homosexual men during a 3-year follow-up period.
Journal of internal medicine 1989;225(6):403-9.
1989: Jan Gerstoft; G Pallesen; L R Mathiesen; Court Pedersen; J Gaub; B O Lindhardt
The value of lymph node histology in human immunodeficiency virus related persistent generalized lymphadenopathy.
APMIS. Supplementum 1989;8():24-7.
1989: B Hofmann; Ib C Bygbjerg; Ebbe Dickmeiss; Viggo Faber; Birgitte Frederiksen; J Gaub; Jan Gerstoft; B K Jakobsen; K D Jakobsen; B O Lindhardt
Prognostic value of immunologic abnormalities and HIV antigenemia in asymptomatic HIV-infected individuals: proposal of immunologic staging.
Scandinavian journal of infectious diseases 1989;21(6):633-43.
1988: L K Munck; CS Petersen; K Bech; A C Thomsen; S Kroon; A M Worm; G L Wantzin; Jan Gerstoft
Hepatitis B in symptomless Danish homosexual men.
Genitourinary medicine 1988;64(1):39-42.
1988: B Hofmann; P Kryger; N S Pedersen; Jens Ole Nielsen; J Oehlenschlager; E A Koerner; T van den Berg; H H Sprechler; C M Nielsen; Jan Gerstoft
Sexually transmitted diseases, antibodies to human immunodeficiency virus, and subsequent development of acquired immunodeficiency syndrome. Visitors of homosexual sauna clubs in Copenhagen: 1982-1983.
Sexually transmitted diseases 1988;15(1):1-4.
1988: B Hofmann; P B Nielsen; Niels Odum; Jan Gerstoft; P Platz; L P Ryder; A G Poulsen; Lars Mathiesen; Ebbe Dickmeiss; B Norrild
Humoral and cellular responses to Pneumocystis carinii, CMV, and herpes simplex in patients with AIDS and in controls.
Scandinavian journal of infectious diseases 1988;20(4):389-94.
1987: Jan Gerstoft
AIDS in Denmark 1980-1984. Immunological, epidemiological and clinical studies among patients and high risk groups.
Danish medical bulletin 1987;34(5):217-34.
1987: Court Pedersen; C M Nielsen; B F Vestergaard; Jan Gerstoft; K Krogsgaard; Jens Ole Nielsen
Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection.
British medical journal (Clinical research ed.) 1987;295(6598):567-9.
1987: B Hofmann; B O Lindhardt; Jan Gerstoft; C S Petersen; P Platz; L P Ryder; Niels Odum; Ebbe Dickmeiss; P B Nielsen; S Ullman
Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies.
British medical journal (Clinical research ed.) 1987;295(6593):293-6.
1987: C M Nielsen; K Hansen; H M Andersen; Jan Gerstoft; B F Vestergaard
A biotin-avidin-amplified inhibition enzyme immunoassay for detection of CMV antibodies in human serum.
Journal of virological methods 1987;16(3):195-208.
1987: C M Nielsen; K Hansen; H M Andersen; Jan Gerstoft; B F Vestergaard
An enzyme labelled nuclear antigen immunoassay for detection of cytomegalovirus IgM antibodies in human serum: specific and non-specific reactions.
Journal of medical virology 1987;22(1):67-76.
1987: J Gaub; Court Pedersen; Anja Poulsen; L R Mathiesen; K Ulrich; B O Lindhardt; Viggo Faber; Jan Gerstoft; B Hofmann; J O Lernestedt
The effect of foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients.
AIDS (London, England) 1987;1(1):27-33.
1987: Jan Gerstoft; G Pallesen; Lars Mathiesen; Ebbe Dickmeiss; B O Lindhardt; B Hofmann; C M Nielsen; CS Petersen; S Kroon
Stages in LAV/HTLV-III lymphadenitis. II. Correlation with clinical and immunological findings.
Scandinavian journal of immunology 1987;25(1):93-9.
1987: B Hofmann; L Fugger; L P Ryder; J Gaub; Niels Odum; P Platz; Jan Gerstoft; A Svejgaard
Immunological studies in acquired immunodeficiency syndrome: effect of TCGF and indomethacine on the in vitro lymphocyte response.
Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc 1987;1():619-26.
1987: Jan Gerstoft; CS Petersen; S Kroon; S Ullman; B O Lindhardt; B Hofmann; J Gaub; Ebbe Dickmeiss
The immunological and clinical outcome of HIV infection: 31 months of follow-up in a cohort of homosexual men.
Scandinavian journal of infectious diseases 1987;19(5):503-9.
1986: P Kolby; Court Pedersen; J H Sindrup; J Gaub; M Arendrup; Jan Gerstoft
The LAV/HTLV-III screening in Copenhagen. Epidemiological results from four clinics over the period 1 July 1984 to 1 April 1985.
Danish medical bulletin 1986;33(5):268-70.
1986: Court Pedersen; P Kolby; J H Sindrup; M Arendrup; H C Wulf; J Gaub; Jan Gerstoft; B O Lindhardt
Immunological studies in homosexual men with and without antibodies to human T-cell lymphotropic virus type III.
Danish medical bulletin 1986;33(5):270-2.
1986: C S Petersen; G L Wantzin; Jan Gerstoft; B O Lindhardt; A M Worm; K Weismann; J K Kristensen; S Kroon; L P Rasmussen; C Avnstorp
[Occurrence of antibody to human T-cell leukemia/lymphovirus type III (LAV/HTLV III) in venereology clientele in Copenhagen].
Ugeskrift for laeger 1986;148(14):821-2.
1985: Jan Gerstoft; Ebbe Dickmeiss; Lars Mathiesen
Cytotoxic capabilities of lymphocytes from patients with the acquired immunodeficiency syndrome.
Scandinavian journal of immunology 1985;22(5):463-70.
1985: B Hofmann; Niels Odum; P Platz; L P Ryder; A Svejgaard; P B Nielsen; W Holten-Andersen; Jan Gerstoft; J O Nielsen; M Mojon
Humoral responses to Pneumocystis carinii in patients with acquired immunodeficiency syndrome and in immunocompromised homosexual men.
The Journal of infectious diseases 1985;152(4):838-40.
1985: B O Lindhardt; Jan Gerstoft; K Ulrich; K Bentzen; E Scheibel; J Dalsgård Nielsen; Ebbe Dickmeiss
Antibodies against HTLV-III in Danish haemophiliacs: relation to source of factor VIII used in treatment and immunological parameters.
Scandinavian journal of haematology 1985;35(4):379-85.
1985: Jan Gerstoft; B O Lindhardt; CS Petersen; S Kroon; S Ullman; S Møller; J O Nielsen; Ebbe Dickmeiss
Antibodies to human T-cell lymphotropic virus type III in promiscuous healthy homosexual men. Relation to immunological and clinical findings.
European journal of clinical investigation 1985;15(5):290-5.
1985: Jan Gerstoft; Jens Ole Nielsen; Ebbe Dickmeiss; T Rønne; P Platz; Lars Mathiesen
The acquired immunodeficiency syndrome (AIDS) in Denmark. A report from the Copenhagen study group of AIDS on the first 20 Danish patients.
Acta medica Scandinavica 1985;217(2):213-24.
1984: Jan Gerstoft; CS Petersen; S Kroon; S Ullman; K Bentsen; Ebbe Dickmeiss; J O Nielsen; H Mogens; K Andersen; I Lorenzen
T lymphocyte subsets in homosexual men from Copenhagen.
European journal of clinical investigation 1984;14(4):301-5.
1984: Jan Gerstoft; K Bentsen; E Scheibel; J Dalsgård-Nielsen; J Gormsen; Ebbe Dickmeiss
Alterations in T-lymphocyte subsets among Danish haemophiliacs: relation to source of factor VIII preparations and high dose factor VIII treatment.
Scandinavian journal of haematology 1984;32(5):544-51.
1984: Jan Gerstoft; Ebbe Dickmeiss; K Bentsen; CS Petersen; S Kroon; S Ullman; J O Nielsen; I Lorenzen
The prognosis of asymptomatic homosexual men with decreased T-helper to T-suppressor ratio.
Scandinavian journal of immunology 1984;19(3):275-80.
1984: P Kryger; Jan Gerstoft; N S Pedersen; Jens Ole Nielsen
Increased prevalence of cytomegalovirus antibodies in homosexual men with syphilis: relation to sexual behaviour.
Scandinavian journal of infectious diseases 1984;16(4):381-4.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.